32 results match your criteria: "University-Hospital of Marche[Affiliation]"
Minerva Pediatr (Torino)
November 2023
Department of Specialized Clinical Sciences and Odontostomatology, Polytechnic University of Marche, Ancona, Italy.
Background: The effect of different neonatal anthropometric charts on the incidence and neurodevelopmental outcomes at two years (Y) corrected age of small-for-gestational-age (SGA) preterm infants has still not been fully explored.
Methods: All preterm infants with a gestational age (GA) between 24.0 and 31.
Int J Pharm Pract
February 2024
Department of Pharmacy, University Hospital of Marche, 71 Via Conca 61012 Ancona, Italy.
Urology
January 2024
Division of Urology, University-Hospital of Marche, Ancona, Italy.
Objective: To assess the relationship between baseline total serum testosterone (T) and clinical outcomes in men affected by Peyronie's disease (PD) stable stage and treated by extra corporeal shockwave therapy (ESWT).
Methods: In this study, 168 patients affected by PD in stable stage (≥12 months) and treated with ESWT, were divided into 2 groups. Group 1 (G1) counted 71 patients with low T levels (≤ 300 ng/dL); group 2 (G2) consisted of 97 patients with normal T that received ESWT with the same protocol of G1 for 6 weeks.
Allergy
November 2023
Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
World J Urol
September 2023
Division of Urology, University-Hospital of Marche, 71 Conca Street, Torrette, 60126, Ancona, Italy.
Radiol Case Rep
August 2023
Department of Specialized Clinical Sciences and Odontostomatology, Polytechnic University of Marche, Ancona, Italy.
Objective: To investigate the feasibility of an ultra-low radiation dose and contrast volume protocol using third-generation dual-source (DS) CT for transcatheter aortic valve implantation (TAVI) planning with coronary artery disease (CAD) assessment, coronary artery calcium score (CACS) and aortic valve calcium score (AVCS) quantification and to evaluate their relationship with TAVI outcome.
Methods: In this retrospective study were selected 203 patients (131 males, 79.4 ± 5.